Results 161 to 170 of about 10,606 (186)

Human anthrax vaccines: Current status and future prospects. [PDF]

Hum Vaccin Immunother
Qiao Z, Wang S, Shi Y, Zhu L, Cui J, Zhang W, Gao J.   +6 more
europepmc   +1 more source

Prevalence, associated factors, and viral load dynamics of hepatitis B virus infection among HIV patients in three healthcare facilities of South Kivu province, eastern Democratic Republic of Congo : Chronic hepatitis B virus among HIV patients in South Kivu province. [PDF]

BMC Infect Dis
Bisimwa PB, Mukonkole JPM, Koyaweda GW, Matabishi CM, Kashosi TM, Mukanga O, Mukengere DM, Nachega JB, Komas NPJ.   +8 more
europepmc   +1 more source

LIVER-R study protocol: a global real-world study of durvalumab-based regimens in patients with hepatobiliary cancers. [PDF]

Future Oncol
Ikeda M, Wörns MA, Akce M, Hsu C, Tebbutt NC, Casadei-Gardini A, Sah J, Farid-Kapadia M, Stirnadel-Farrant HA, Paskow MJ, Baur B, Melillo G, Schmidt J, Daktera A, Knox JJ.   +14 more
europepmc   +1 more source

Prevalence, Molecular Characterization, and Immune Status Response of Hepatitis B Virus Among Healthcare Workers in Yaoundé General Hospital, Cameroon, During May to June 2024: A Hospital-Based Cross-Sectional Study. [PDF]

Health Sci Rep
Atsama-Amougou M, Simo FBN, Tchinda CF, Moukam M, Tongo-Passo M, Moundipa-Fewou P.   +5 more
europepmc   +1 more source

Combined therapy with the estrogen receptor ERα and IFNα-2b suppresses HBV replication by inducing GBP1 expression. [PDF]

Front Immunol
Li Y, Gong J, Tan G, Luo H, Hu X, Qin B.
europepmc   +1 more source

Clinical Applications of Bovine Colostrum in GastrointestinaI Disorders: Mechanisms, Evidence, and Therapeutic Potential. [PDF]

Int J Mol Sci
Karakülah YS, Yalçıntaş YM, Bechelany M, Karav S.   +3 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

The prevalence of “anti‐HBc alone” and HBV DNA detection among anti‐HBc alone in Korea

Journal of Medical Virology, 2010
AbstractThe “anti‐HBc alone” is a frequent serological finding in clinical laboratories, making it difficult to determine whether the HBV infection has resolved. The objectives of this study were to investigate the prevalence of anti‐HBc alone and HBV DNA detection (occult HBV infection) among anti‐HBc alone, and to describe the demographic and ...
So-Young, Kang, Myeong-Hee, Kim, Woo-In, Lee   +2 more
openaire   +2 more sources

Serological pattern ?anti-HBc alone?: Report on a workshop

Journal of Medical Virology, 2000
In areas with low hepatitis B virus (HBV) endemicity such as most parts of Europe and the United States “anti-HBc alone” is found in 10–20% of all individuals with HBV markers, i.e., 1–4% of the population. In about 10% of these individuals HBV DNA is detected by PCR, the proportions varying greatly depending on the population studied, being highest in
P. Grob, W. Jilg, H. Bornhak, G. Gerken, W. Gerlich, S. Günther, G. Hess, H. Hüdig, A. Kitchen, H. Margolis, G. Michel, C. Trepo, H. Will, A.R. Zanetti, I. Mushahwar   +14 more
openaire   +2 more sources